Your browser doesn't support javascript.
loading
The evolution of factor XI and the kallikrein-kinin system.
Ponczek, Michal B; Shamanaev, Aleksandr; LaPlace, Alec; Dickeson, S Kent; Srivastava, Priyanka; Sun, Mao-Fu; Gruber, Andras; Kastrup, Christian; Emsley, Jonas; Gailani, David.
Affiliation
  • Ponczek MB; Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
  • Shamanaev A; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
  • LaPlace A; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
  • Dickeson SK; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
  • Srivastava P; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
  • Sun MF; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
  • Gruber A; Department of Biomedical Engineering and.
  • Kastrup C; Division of Hematology and Medical Oncology, School of Medicine, Oregon Health and Sciences University, Portland, OR.
  • Emsley J; Aronora, Inc., Portland, OR.
  • Gailani D; Michael Smith Laboratories and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada; and.
Blood Adv ; 4(24): 6135-6147, 2020 12 22.
Article de En | MEDLINE | ID: mdl-33351111
ABSTRACT
Factor XI (FXI) is the zymogen of a plasma protease (FXIa) that contributes to hemostasis by activating factor IX (FIX). In the original cascade model of coagulation, FXI is converted to FXIa by factor XIIa (FXIIa), a component, along with prekallikrein and high-molecular-weight kininogen (HK), of the plasma kallikrein-kinin system (KKS). More recent coagulation models emphasize thrombin as a FXI activator, bypassing the need for FXIIa and the KKS. We took an evolutionary approach to better understand the relationship of FXI to the KKS and thrombin generation. BLAST searches were conducted for FXI, FXII, prekallikrein, and HK using genomes for multiple vertebrate species. The analysis shows the KKS appeared in lobe-finned fish, the ancestors of all land vertebrates. FXI arose later from a duplication of the prekallikrein gene early in mammalian evolution. Features of FXI that facilitate efficient FIX activation are present in all living mammals, including primitive egg-laying monotremes, and may represent enhancement of FIX-activating activity inherent in prekallikrein. FXI activation by thrombin is a more recent acquisition, appearing in placental mammals. These findings suggest FXI activation by FXIIa may be more important to hemostasis in primitive mammals than in placental mammals. FXI activation by thrombin places FXI partially under control of the vitamin K-dependent coagulation mechanism, reducing the importance of the KKS in blood coagulation. This would explain why humans with FXI deficiency have a bleeding abnormality, whereas those lacking components of the KKS do not.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur XI / Déficit en facteur XI Type d'étude: Prognostic_studies Limites: Animals / Female / Humans / Pregnancy Langue: En Journal: Blood Adv Année: 2020 Type de document: Article Pays d'affiliation: Pologne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur XI / Déficit en facteur XI Type d'étude: Prognostic_studies Limites: Animals / Female / Humans / Pregnancy Langue: En Journal: Blood Adv Année: 2020 Type de document: Article Pays d'affiliation: Pologne